My Lords, the only thing that I will add is that the noble Lord, Lord Field of Birkenhead, said that this was about equality. My point is that MHRA’s approach to medicinal cannabis is the approach it takes to licensing all other medicines. So whatever approach we take to evidence, or how we look at the appropriate gathering of that evidence, will be based on the approach we take to all medicines. The way in which cannabis is treated is not as a different or exceptional case, and we will want to ensure that that is the case going forwards.
Medicines and Medical Devices Bill
Proceeding contribution from
Baroness Penn
(Conservative)
in the House of Lords on Wednesday, 11 November 2020.
It occurred during Debate on bills
and
Committee proceeding on Medicines and Medical Devices Bill.
About this proceeding contribution
Reference
807 c504GC Session
2019-21Chamber / Committee
House of Lords Grand CommitteeSubjects
Librarians' tools
Timestamp
2024-04-29 17:14:38 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000040
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000040
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000040